| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/29/1998 | EP0837883A2 Method of solubilizing, purifying, and refolding protein |
| 04/29/1998 | EP0837881A2 CONJUGATES OF alpha-MSH WITH A FATTY ACID, PREPARATION METHOD THEREFOR, AND USE THEREOF AS A DRUG |
| 04/29/1998 | EP0837880A2 Enamel matrix related polypeptide |
| 04/29/1998 | EP0837878A1 Antitumor proteins from rana pipiens oocytes |
| 04/29/1998 | EP0837875A2 Inhibitors of farnesyl-protein transferase |
| 04/29/1998 | EP0837845A1 Herpes ribonucleotide reductase inhibitors |
| 04/29/1998 | EP0837696A1 Improved delivery of diagnostic and therapeutic agents to a target site |
| 04/29/1998 | EP0837693A1 Method of treating rheumatoid arthritis with low dose type ii collagen |
| 04/29/1998 | EP0837691A1 Vaccination with peptide of mhc class ii molecules for treatment of autoimmune disease |
| 04/29/1998 | EP0837690A1 A stabilized pharmaceutical formulation comprising a growth hormone and a peptide comprising at least one basic amino acid residue and at least one acid amino acid residue |
| 04/29/1998 | EP0837689A1 Anti-metastatic and anti-angiogenic pharmaceutical compositions |
| 04/29/1998 | EP0837687A1 Hapten modified tumor cell extract and methods of treating or screening for cancer |
| 04/29/1998 | EP0837673A2 Polymeric lamellar substrate particles for drug delivery |
| 04/29/1998 | EP0837672A1 Preparations and methods for the treatment of t cell mediated diseases |
| 04/29/1998 | EP0837630A1 Prodrugs of pharmaceuticals with improved bioavailability |
| 04/29/1998 | EP0837629A1 Pericardial therapeutic and diagnostic agent delivery |
| 04/29/1998 | EP0537191B1 Treatment of organ transplantation rejection |
| 04/29/1998 | EP0465529B1 Expression of exogenous polynucleotide sequences in a vertebrate |
| 04/29/1998 | CN1180314A Combination of angiotensin converting enzyme inhibitor and side-effect-reduced amount of aldosterone antagonist |
| 04/29/1998 | CN1180313A Combination of angiotensin converting enzyme inhibitor, side-effect-reduced amount of aldosterone antagonist and diuretic |
| 04/29/1998 | CN1180312A Anti-obesity proteins |
| 04/29/1998 | CN1180106A Glucokinase gene and its high expression engineering strain |
| 04/29/1998 | CN1179980A Pharmaceutical composition for prophylaxis and/or treatment of apoptosis-related diseases |
| 04/29/1998 | CN1179979A Ophithalmic formulation for treating myopia comprising dopamine agonist and cyclodextrin |
| 04/29/1998 | CA2214866A1 Novel spo-rel |
| 04/28/1998 | US5744621 Cis-epoxide compounds |
| 04/28/1998 | US5744593 Parasitic helminth larval thiol specific antioxidant proteins and nucleic acid molecules |
| 04/28/1998 | US5744586 Manufacturing process for the production of purified transferrin |
| 04/28/1998 | US5744585 Human monoclonal antibody against lung carcinoma |
| 04/28/1998 | US5744584 Antithrombosis agents |
| 04/28/1998 | US5744580 Fusion protein |
| 04/28/1998 | US5744545 Biocompatible adhesive compositions |
| 04/28/1998 | US5744496 Method of treating cardiac insufficiency using angiotensin-converting enzyme inhibitors |
| 04/28/1998 | US5744487 Prolineamide derivatives |
| 04/28/1998 | US5744486 Pyridinone thrombin inhibitors |
| 04/28/1998 | US5744481 β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 04/28/1998 | US5744477 Administering an inhibitor in combination with restricting the caloric intake of the subject |
| 04/28/1998 | US5744461 Viricides |
| 04/28/1998 | US5744451 N-substituted glutamic acid derivatives with interleukin-1 β converting enzyme inhibitory activity |
| 04/28/1998 | US5744450 GnRH analogs |
| 04/28/1998 | US5744449 Lethal toxin neutralizing factors |
| 04/28/1998 | US5744448 Human follicle stimulating hormone receptor |
| 04/28/1998 | US5744446 Hybrid human/animal factor VIII |
| 04/28/1998 | US5744445 Cystic fibrosis, neoplasias, bronchogenic cancers, pneumonia, broncopulmonary microbial infections; delivered by mouth or aerosol to respiratory or gastrointestinal systems |
| 04/28/1998 | US5744444 HPTH-fragment-(1-37), the preparation thereof, medicaments containing same and the use thereof |
| 04/28/1998 | US5744442 Regulation of cellular invasiveness |
| 04/28/1998 | US5744363 Injecting cell culture medium into isolated tumor and flushing out tumor cells |
| 04/28/1998 | US5744362 Antisense oligonucleotide modulation of raf gene expression |
| 04/28/1998 | US5744338 DNA encoding seryl tRNA synthetase from Staphylococcus aureus |
| 04/28/1998 | US5744329 DNA encoding fused di-beta globins and production of pseudotetrameric hemoglobin |
| 04/28/1998 | US5744318 Contacting sample with monoclonal antibody or antigen binding fragment thereof, detecting formation of reaction complexes with advanced glycosylation endproducts |
| 04/28/1998 | US5744316 Used to identify individuals diagnosed with conditions characterized by cellular abnormalities |
| 04/28/1998 | US5744313 Assay employing novel protein domain which binds tyrosine phosphorylated proteins |
| 04/28/1998 | US5744304 Introducing into cell vector including selected protein gene under control of heterologous inflammation responsive promoter, contacting with cytokine which activates gene to express protein |
| 04/28/1998 | US5744300 Screening to identify one or more test compounds that can alter gene expression in senescent cells |
| 04/28/1998 | US5744163 Sustained release formulation of animal growth hormone and process for preparation thereof |
| 04/28/1998 | US5744157 Preparation for maintaining and/or increasing muscular power and body cell mass |
| 04/28/1998 | US5744156 Use of a substance P antagonist for the treatment of skin reddening of neurogenic origin |
| 04/28/1998 | US5744143 Viral vaccines |
| 04/28/1998 | US5744139 Determining that human has a depressed t4/t8 ratio, administering an effective amount of somatomedins and monitoring the ratio of t4/t8; useful for traeting trauma due to head injury, viral and bacterial infections |
| 04/28/1998 | US5744133 Expression of a tumor-specific antigen by a recombinant vector virus and use thereof in preventitive or curative treatment of the corresponding tumor |
| 04/28/1998 | US5744132 Formulations for IL-12 |
| 04/28/1998 | US5744128 Use of emu oil for stimulating skin and hair growth |
| 04/28/1998 | US5744002 Paper strengthened with solubilized collagen and method |
| 04/28/1998 | US5743250 Insulin delivery enhanced by coached breathing |
| 04/28/1998 | CA2124835C Cyclopropyl n-hydroxyureas and n-hydroxyacetamides which inhibit lipoxygenase |
| 04/28/1998 | CA2102859C Expression vector for phytolacca antiviral protein |
| 04/28/1998 | CA2057926C Chemical products |
| 04/28/1998 | CA2030108C Process for the preparation of genetic vectors for the expression of nerve growth factor in eukaryotic cells |
| 04/28/1998 | CA1339843C Synergistic human interferon activity |
| 04/25/1998 | CA2188903A1 Anti cancer therapy and compositions |
| 04/23/1998 | WO1998016655A1 Human plasma hyaluronidase |
| 04/23/1998 | WO1998016646A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 04/23/1998 | WO1998016644A1 Fibroblast growth factor homologs |
| 04/23/1998 | WO1998016643A1 Brain-associated inhibitor of tissue-type plasminogen activator |
| 04/23/1998 | WO1998016642A1 Keratinocyte growth factor-2 products |
| 04/23/1998 | WO1998016641A1 Isolation and method of using tissue growth-inducing frzb protein |
| 04/23/1998 | WO1998016640A1 Human reg i-gamma protein |
| 04/23/1998 | WO1998016638A1 Consolidated ligands with increased affinities and methods of use thereof |
| 04/23/1998 | WO1998016637A1 Fanconi gene 1 |
| 04/23/1998 | WO1998016558A1 METHOD FOR PRODUCING AN IgM PREPARATION FOR INTRAVENOUS ADMINISTRATION |
| 04/23/1998 | WO1998016557A1 Assays for g-protein-linked receptors |
| 04/23/1998 | WO1998016556A1 Pharmaceutical and diagnostic use of serum amyloid p component |
| 04/23/1998 | WO1998016555A1 Polypeptide transition metal salts and method of enhancing anti-hiv activity of polypeptide |
| 04/23/1998 | WO1998016551A2 Variants of vascular endothelial cell growth factor having antagonistic properties |
| 04/23/1998 | WO1998016549A1 Antimicrobial peptide analogs of gramicidin s and compositions comprising them |
| 04/23/1998 | WO1998016548A1 Thrombin receptor peptides and uses thereof |
| 04/23/1998 | WO1998016547A1 SELECTIVE FACTOR Xa INHIBITORS |
| 04/23/1998 | WO1998016545A1 Therapeutic proteins |
| 04/23/1998 | WO1998016542A1 NOVEL PENICILLIN BINDING PROTEIN FROM $i(STREPTOCOCCUS PNEUMONIAE) |
| 04/23/1998 | WO1998016532A1 Triterpene derivatives with immunosuppressant activity |
| 04/23/1998 | WO1998016531A1 Triterpene derivatives with immunosupressant activity |
| 04/23/1998 | WO1998016525A1 SELECTIVE FACTOR Xa INHIBITORS |
| 04/23/1998 | WO1998016524A1 HETEROCYCLIC DERIVATIVES AS FACTOR Xa INHIBITORS |
| 04/23/1998 | WO1998016523A2 Selective factor xa inhibitors |
| 04/23/1998 | WO1998016518A1 Triterpene derivatives with immunosuppressant activity |
| 04/23/1998 | WO1998016505A1 SULFONAMIDE INTERLEUKIN-1β CONVERTING ENZYME INHIBITORS |
| 04/23/1998 | WO1998016502A1 ASPARTATE ESTER INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
| 04/23/1998 | WO1998016254A1 Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system |
| 04/23/1998 | WO1998016252A1 New pharmaceutical parenteral formulation of a thrombin inhibitor |